Diagnostic imaging manufacturers face problems if major insurersproceed with plans to consolidate their medical technology assessmentsefforts, according to Bobby J. Bowen, vice president of GE MedicalSystems' advanced technology division. The joint
Diagnostic imaging manufacturers face problems if major insurersproceed with plans to consolidate their medical technology assessmentsefforts, according to Bobby J. Bowen, vice president of GE MedicalSystems' advanced technology division.
The joint insurance company effort could centralize tremendouspower among groups that place cost control ahead of the medicalefficacy of emerging technologies, Bowen said. He addressed theNational Symposium on the Economics of Diagnostic Imaging in Washington,DC, last month.
The trend could raise more barriers to reimbursement of newimaging applications and force manufacturers to underwrite additionalresearch evaluating the cost implications of the technology theycreate, he said.
"Tying payment directly to cost-effectiveness is a significantphilosophical departure from the former standard of clinical usefulness.For manufacturers, this represents a major new hurdle for entryof products into the radiology market," he said.
The source of Bowen's concern is a joint effort by Aetna, Cigna,Kaiser-Permanente Health Plan, Metropolitan, Prudential and TheTravelers insurance companies and several Blue Cross/Blue Shieldplans. Those companies recently agreed to centralize all medicaltechnology assessments for their members.
The group is considering two plans of attack, Bowen said. Oneis a private-sector approach limited to the insurers. The otheris a public/private partnership in cooperation with the Agencyfor Health Care Policy and Research, the medical technology assessmentbranch of the federal Public Health Service.
The group would establish a central clearing house to collect,evaluate and distribute information about the safety, efficacyand cost-effectiveness of emerging diagnostic imaging technology.It would finance additional research on these topics and makeresults available to payers, providers and the general public.
The plan continued to send shock waves through the imagingmanufacturing sector even after the effort was stalled by theBush administration and the Office of Management and Budget, Bowensaid.
"The idea of a single, centralized group of omniscientgurus deciding what is good and bad for health care is frightening,"he said.
Disclosure of the insurance companies' plan came on the heelsof several other developments that could complicate the introductionof new diagnostic technology, Bowen said. Among these are theHealth Care Financing Administration's use of cost-effectivenesscriteria for granting Medicare reimbursement, the increasinglycostly and time-consuming FDA approval process, and dwindlingfinancial support for university-based radiological research.
These trends may force the manufacturers to take the same routethe insurers are contemplating, Bowen said.
"The industry may have to look at setting up some sortof consortium activity to cut the total research time and costby sharing data," he said.
Bowen itemized five priorities for industry attention. Manufacturersshould underwrite the training of radiology researchers; use theirmedical advisory boards to assess research priorities and methods;influence health-care outcomes policy-making; develop their ownoutcomes data; and continue close surveillance of new technologydevelopments, he said.
A Victory for Radiology: New CMS Proposal Would Provide Coverage of CT Colonography in 2025
July 12th 2024In newly issued proposals addressing changes to coverage for Medicare services in 2025, the Centers for Medicare and Medicaid Services (CMS) announced its intent to provide coverage of computed tomography colonography (CTC) for Medicare beneficiaries in 2025.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
ACR Collaborative Model Leads to 35 Percent Improvement with Mammography Positioning Criteria
July 1st 2024Noting significant variation with facilities for achieving passing criteria for mammography positioning, researchers found that structured interventions, ranging from weekly auditing of images taken by technologists to mechanisms for feedback from radiologists to technologists, led to significant improvements in a multicenter study.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.